Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Pein H, Ville A, Pace S, Temml V, Garscha U, Raasch M et al (2018) Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase
General health and lifestyle: Skin Whitening shots efficacy depends on lifestyle, diet, and skincare
A transplant during an active shedding phase would even be counterproductive, because the transplanted hairs land in the same stressed environment and can also tip into the resting phase